Rare Disease Drug Development
-- viewing now**Rare Disease Drug Development: A Journey to Cure a Rare Condition** **For those living with rare diseases, hope is not lost.** Rare disease drug development is a complex and challenging but ultimately rewarding field of research.
3,772+
Students enrolled
GBP £ 149
GBP £ 215
Save 44% with our special offer
About this course
Our mission is to unlock the potential of innovative therapies that can transform lives and bring hope to those affected by rare diseases.
**Our focus is on:**
* **Understanding the underlying causes of rare diseases**
* **Developing novel therapeutic solutions**
* **Conducting clinical trials to ensure safety and efficacy**
**We invite you to join our mission and support the fight for a cure.** Together, we can make a significant difference in the lives of those living with rare diseases.
**Call to Action:**
**Explore the latest advancements in rare disease drug development and join our efforts to find a cure for your loved one.**
100% online
Learn from anywhere
Shareable certificate
Add to your LinkedIn profile
2 months to complete
at 2-3 hours a week
Start anytime
No waiting period
Course details
## Essential Units for Rare Disease Drug Development
**Drug Discovery**
* **CRISPR-Cas9:** A gene-editing tool used to modify specific genes in cells.
* **High-throughput screening (HTS):** A method used to identify and evaluate potential drug candidates.
* **High-content screening (HCS):** A method used to identify and evaluate potential drug candidates by analyzing large datasets.
* **Computer-aided drug discovery (CADD):** A computational tool used to identify and prioritize potential drug candidates.
* **Preclinical research:** Testing potential drugs in animals to identify those that are safe and effective.
**Clinical Development**
* **Phase I clinical trial:** The first stage of clinical development, testing the safety and tolerability of a drug in a small group of volunteers.
* **Phase II clinical trial:** The second stage of clinical development, testing the efficacy of a drug in a larger group of volunteers.
* **Phase III clinical trial:** The third stage of clinical development, testing the efficacy and safety of a drug in a large group of volunteers.
* **New Drug Application (NDA):** A formal application to the FDA requesting approval of a new drug.
* **Clinical trial data:** Data collected from clinical trials that support the approval of a drug.
**Regulatory Approval**
* **Food and Drug Administration (FDA):** The US regulatory agency responsible for approving new drugs and medical devices.
* **European Medicines Agency (EMA):** The European regulatory agency responsible for approving new drugs and medical devices.
* **Health Canada:** The Canadian regulatory agency responsible for approving new drugs and medical devices.
**Post-Approval**
* **Post-marketing surveillance:** Monitoring the safety and efficacy of a drug after it is approved.
* **Patient support:** Providing support and resources to patients who are taking a drug.
* **Research and development:** Continuously developing new drugs and therapies for rare diseases.
**Other Important Units**
* **Rare Disease Network (RDD):** A non-profit organization that supports research and patient care for rare diseases.
* **Orphanet:** A database that contains information on rare diseases and their treatments.
* **ClinicalTrials.gov:** A government website that provides information on clinical trials for rare diseases.
Career path
```html
```
**Note:** This code requires the Google Charts JavaScript library to be loaded on the page. Make sure to include the Google Charts library in your project.
Entry requirements
- Basic understanding of the subject matter
- Proficiency in English language
- Computer and internet access
- Basic computer skills
- Dedication to complete the course
No prior formal qualifications required. Course designed for accessibility.
Course status
This course provides practical knowledge and skills for professional development. It is:
- Not accredited by a recognized body
- Not regulated by an authorized institution
- Complementary to formal qualifications
You'll receive a certificate of completion upon successfully finishing the course.
Why people choose us for their career
Loading reviews...
Frequently Asked Questions
Debug: False
Course fee
MOST POPULAR
Fast Track
GBP £149
Complete in 1 month
Accelerated Learning Path
- 3-4 hours per week
- Early certificate delivery
- Open enrollment - start anytime
Standard Mode
GBP £99
Complete in 2 months
Flexible Learning Pace
- 2-3 hours per week
- Regular certificate delivery
- Open enrollment - start anytime
What's included in both plans:
- Full course access
- Digital certificate
- Course materials
All-Inclusive Pricing • No hidden fees or additional costs
Get course information
Earn a career certificate
RARE DISEASE DRUG DEVELOPMENT
is awarded to
Learner Name
who has completed a programme at
London School of Planning and Management (LSPM)
Awarded on
05 May 2025
Blockchain Id: s-1-a-2-m-3-p-4-l-5-e
Add this credential to your LinkedIn profile, resume, or CV. Share it on social media and in your performance review.
